04 / Evidence Base

Phase II data. Peer-reviewed results.

HEALIX Cast: Phase II RCTs across 6 academic centres. HEALIX Patch: bench validation and murine wound model studies. All figures are peer-reviewed or presented at indexed conferences.

0
%

reduction in post-operative medication errors compared to standard PRN prescribing protocols

n=312 · RCT Phase II · JAMA Surgery 2025
0
%

faster time to radiographic bone union with PEMF stimulation protocol

n=180 · AAOS Annual Meeting 2025
0
%

sensitivity for early sepsis detection, 4.1 hours before clinical signs appear

n=445 · IDSA 2025 · Lancet Infectious Diseases
0
%

reduction in ICU admissions due to wound sepsis in surgical ward pilot

n=228 · Johns Hopkins Hospital 2024–25
0
×

improvement in patient-reported pain control scores vs opioid PRN scheduling

n=312 · VAS scale · blinded assessment
0
%

uptime across all deployed units in 18-month post-market surveillance study

n=1,200 devices · 23 hospitals

Key Publications & Presentations

JAMA Surgery

"Closed-loop analgesic delivery via smart cast reduces opioid consumption by 41% in long-bone fracture: a randomised controlled trial." Published 2025.

Lancet Infectious Diseases

"Multi-biomarker patch for real-time sepsis surveillance in post-surgical patients: diagnostic accuracy and time-to-detection." Published 2025.

Nature Biomedical Engineering

"On-device federated learning for personalised pharmacokinetic modelling in implantable drug delivery systems." Published 2024.

AAOS 2025

"PEMF stimulation integrated with biosensor cast accelerates callus formation: interim results of the CASTPEMF-II trial."